Cambridge, MA, United States of America

Thomas Mccauley

USPTO Granted Patents = 15 

 

 

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 59(Granted Patents)


Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: Innovations by Thomas G McCauley

Introduction: Thomas G McCauley is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of ophthalmology. With a total of seven patents to his name, he has focused on developing methods and compositions aimed at reducing intraocular pressure, which is crucial in the treatment of glaucoma and ocular hypertension.

Latest Patents: Among his latest patents is a composition or kit designed to reduce intraocular pressure. This invention combines a prostaglandin analog with an adenosine receptor A agonist. The method involves using this combination to effectively lower intraocular pressure in subjects. Another significant patent outlines a method for reducing intraocular pressure in humans using N6-cyclopentyladenosine (CPA) and its derivatives. This method emphasizes the importance of corneal permeability in delivering effective treatments for elevated intraocular pressure.

Career Highlights: Thomas G McCauley is currently associated with Inotek Pharmaceuticals Corporation, where he continues to innovate in the field of eye care. His work has been instrumental in advancing therapeutic options for patients suffering from conditions that affect intraocular pressure.

Collaborations: Throughout his career, McCauley has collaborated with esteemed colleagues such as Norman N Kim and William K McVicar. These partnerships have contributed to the development of his innovative solutions in ophthalmology.

Conclusion: Thomas G McCauley's contributions to the field of ophthalmology through his patents and collaborations highlight his commitment to improving patient care. His innovative approaches to reducing intraocular pressure are paving the way for advancements in the treatment of glaucoma and ocular hypertension.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…